The Blue Venture Fund

Founded 2008

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 12
Rounds per year 0.69
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Health Diagnostics
  • Software
  • Biotechnology

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CirrusMD

Health Care
Hospital
mHealth
Mobile Devices
$20M31 Mar 2021 Denver, Colorado, United States

Upward Health

02 Mar 2021 Providence, Rhode Island, United States

Lumiata

Health Care
Machine Learning
Predictive Analytics
Risk Management
$14M14 Jan 2021 California, United States

Octave Bioscience

Biotechnology
Clinical Trials
Health Care
Health Diagnostics
Medical
$32M17 Dec 2020 United States, " United States"}

Onc.AI

Biotechnology
Health Diagnostics
Medical
Software
$6M02 Dec 2020 California, United States

Owl Insights

Education
Health Care
Predictive Analytics
Psychology
SaaS
$15M08 Sep 2020 Seattle, Washington, United States

Somatus

Health Care
Health Diagnostics
Medical
$64M23 Jun 2020 Virginia, United States

Analytics
Health Care
Information Technology
SaaS
Software
$35M16 Jun 2020 New York, New York, United States

Oncology Analytics

Analytics
Health Care
$28M26 May 2020 Atlanta, Georgia, United States
News
Drips Receives Growth Investment from the Blue Venture Fund

– Drips secured a growth investment from the Blue Venture Fund to support the company’s vision of enabling healthcare organizations to connect with their members and patients during critical moments through its conversational AI platform.
– This investment follows the previously announced investment from leading software investor Accel-KKR and its credit facility with Wells Fargo Capital Finance’s Technology Finance group.

Ultromics Raises $33M in Series B Funding

– Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging solutions, raised $33M in series B funding.
– The round was led by Blue Venture Fund with participation from Optum Ventures, GV and Oxford Sciences Innovation.
– The new investment will be aimed at accelerating the use of AI-enabled echocardiograms to improve patient care, and bring improved diagnostic quality and resource savings to hospitals.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Blue Venture Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: